Singapore markets closed

Vaxcyte, Inc. (PCVX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.71+3.16 (+5.22%)
At close: 04:00PM EDT
63.71 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.93B
Enterprise value 5.88B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.59
Enterprise value/revenue N/A
Enterprise value/EBITDA -14.99

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 329.02%
S&P500 52-week change 323.57%
52-week high 382.04
52-week low 344.20
50-day moving average 367.31
200-day moving average 357.82

Share statistics

Avg vol (3-month) 3745.95k
Avg vol (10-day) 3785.44k
Shares outstanding 5108.76M
Implied shares outstanding 6108.76M
Float 899.24M
% held by insiders 10.60%
% held by institutions 196.67%
Shares short (15 Apr 2024) 48.24M
Short ratio (15 Apr 2024) 412.65
Short % of float (15 Apr 2024) 48.78%
Short % of shares outstanding (15 Apr 2024) 47.58%
Shares short (prior month 15 Mar 2024) 48.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-24.24%
Return on equity (ttm)-36.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -464.88M
Net income avi to common (ttm)-402.27M
Diluted EPS (ttm)-4.14
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.08B
Total cash per share (mrq)9.96
Total debt (mrq)29.22M
Total debt/equity (mrq)2.36%
Current ratio (mrq)7.54
Book value per share (mrq)13.01

Cash flow statement

Operating cash flow (ttm)-296.79M
Levered free cash flow (ttm)-202.41M